Depending on one’s perspective, “mast cell activation syndrome (MCAS)” is either a relatively rare, narrowly defined severe allergic condition or a vastly under-recognized underlying cause of multiple chronic inflammatory conditions that affect roughly 17% of the entire population. Inappropriate activation of mast cells — now termed mast cell activation disease (MCAD) — has long been …
